Lantheus Holdings
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, PrecisionDiagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements inEurope, Canada, Australia, Asia-Pacific, Central America and South America.
公司地址 201 Burlington Road, South Building, Bedford, MA, USA, 01730
電話號碼 +1 978 671-8001
傳真號碼 +1 978 671-8860
公司網頁 https://www.lantheus.com
員工數量 1193
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Mary Anne Heino Chairman of the Board and Chief Executive Officer 美元 255.58K 26/02/2026
Ms. Kimberly Brown Chief Accounting Officer -- 26/02/2026
Ms. Jamie Spaeth Chief People Officer -- 21/03/2025
Mr. Robert J. Marshall, Jr Chief Financial Officer and Treasurer 美元 669.00K 26/02/2026
Ms. Amanda Morgan Chief Commercial Officer 美元 504.82K 06/11/2025
Dr. Jean-Claude Provost Chief Science Officer 美元 548.53K 21/03/2025
Mr. Daniel M. Niedzwiecki Chief Administrative Officer, General Counsel and Corporate Secretary 美元 555.79K 21/03/2025
 
董事會成員
董事會 職務 更新日期
Dr. James H. Thrall, M.D. Independent Director 26/02/2026
Mr. Samuel R. Leno Independent Director 26/02/2026
Ms. Mary Anne Heino Chairman of the Board and Chief Executive Officer 26/02/2026
Ms. Julie H. McHugh Lead Independent Director 26/02/2026
Ms. Julie M. Eastland Independent Director 26/02/2026
Mr. Gary John Pruden Independent Director 26/02/2026
Dr. Phuong Khanh Morrow, F.A.C.P. Independent Director 26/02/2026
Ms. Minnie V. Baylor-Henry Independent Director 26/02/2026
Dr. Gerard Ber, PhD Independent Director 26/02/2026
Mr. Heinz Mausli Independent Director 26/02/2026
 
所屬ETF (更新日期: 07/03/2026 03:45)
代號 名稱 佔比% ▼ 持有日期
NDOWAnydrus Advantage ETF<0.000001%07/08/2025
OPTZOptimize Strategy Index ETF<0.000001%22/09/2025
PDPInvesco Dorsey Wright Momentum ETF<0.000001%01/07/2025
PTHInvesco Dorsey Wright Healthcare MomtETF<0.000001%01/07/2025
PTLInspire 500 ETF<0.000001%01/10/2025
QMIDWisdomTree U.S. Mid Cap Quality Gr<0.000001%09/12/2025
QVALAlpha Architect US Quantitative Val ETF<0.000001%29/08/2025
RFGInvesco S&P MidCap 400® Pure Growth ETF<0.000001%22/12/2025
ROEAstoria US Equal Weight Quality KingsETF<0.000001%30/06/2025
RVTRoyce Small-Cap Trust<0.000001%30/06/2025
SCHKSchwab 1000 ETF<0.000001%23/09/2025
SCHMSchwab US Mid-Cap ETF™<0.000001%23/09/2025
SLYSPDR® S&P 600 Small Cap ETF<0.000001%12/10/2022
SMMDiShares Russell 2500 ETF<0.000001%27/02/2026
SPXXNuveen S&P 500 Dynamic Overwrite<0.000001%31/07/2025
SSPXJanus Henderson US Sustainable Eq ETF<0.000001%12/09/2025
STXMStrive Mid-Cap ETF<0.000001%11/09/2025
SYZLazard US Systematic Small Cap Eq ETF<0.000001%30/06/2025
TMEDT. Rowe Price Health Care ETF<0.000001%13/08/2025
USMFWisdomTree US Multifactor<0.000001%12/06/2025
  1    2    3    4    5    6    7   8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.